https://www.biospace.com/outlook-therapeutics-to-present-at-the-retina-subspecialty-day-american-academy-of-ophthalmology-2021-annual-conference
Outlook Therapeutics to Present at the Retina Subspecialty Day, American Academy of Ophthalmology...
Nov 5, 2021 - Outlook Therapeutics, Inc., a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in...
to presentthe retinasubspecialty dayoutlooktherapeutics